JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 26 No. 12 1382-1385
© 1985 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplan, W. D.
Right arrow Articles by Atkins, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaplan, W. D.
Right arrow Articles by Atkins, H. L.

Clinical Comparison of Two Radiocolloids for Internal Mammary Lymphoscintigraphy

W. D. Kaplan, C. W. Piez, R. S. Gelman, S. M. Laffin, E. M. Rosenbaum, C. A. Jennings, C. A. McCormick, J. R. Harris, I. C. Henderson and H. L. Atkins

Divisions of Nuclear Medicine, Biostatistics, and Epidemiology, and Departments of Radiation Therapy and Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Correspondence: For reprints contact: William D. Kaplan, MD, Div. of Nuclear Medicine, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115.

ABSTRACT

Recent studies suggest that 99mTc-labeled radiocolloid (SC) compounded with hydrogen sulfide can be used to visualize lymph channels and nodes. Our study prospectively compared SC with 99mTc antimony sulfide (SbS) colloid, in 28 patients undergoing internal mammary lymphoscintigraphy. Images were recorded on a scintillation camera and computer at 0.5, 1.0, and 3.0 hr. Quantitative analysis included assessment of percent (%) injected dose in nodes, the percent remaining at the injection site, and the relative intensity of the most cephalad node compared to a 57Co standard. The mean (x) % injected dose of both radiocolloids within visualized nodes was less than 1% at each time interval, with no significant differences between x's. The x % injected dose remaining at the injection site at 3.0 hr was 83 for SbS and 76 for SC not statistically significant (N.S.). The x of the ratio of counts within the most cephalad node at 3.0 hr to counts within a 57Co standard was 0.98 for SbS and 1.03 for SC (N.S.). Clinical assessment of number of nodes visualized and extent of radiocolloid migration showed no difference between the two agents. The biological and clinical parameters for the two colloids appear similar when used for internal mammary lymphoscintigraphy.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1985 by the Society of Nuclear Medicine.